Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penny E Mohr

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Policy Analysis Brief. W Series|July 9, 2004
The implementation of Medicare's outpatient prospective payment system and specific concerns for rural hospitalsPenny E Mohr, Sreelata Kintala
Journal of Managed Care & Specialty Pharmacy|May 27, 2014
Medical and pharmacy coverage decision making at the population levelPenny E Mohr, Sean R Tunis
Pharmacoeconomics|January 21, 2010
Access with evidence development: the US experiencePenny E Mohr, Sean R Tunis
Arthritis and Rheumatism|May 30, 2009
Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritisJennifer M Polinski, Penny E Mohr, Lorraine Johnson
Schizophrenia Research|September 18, 2004
Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scoresLeslie A Lenert, Ann P Sturley, Mark H Rapaport, et al.
Contemporary Clinical Trials|September 4, 2013
Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payersSeema S Sonnad, C Daniel Mullins, Danielle Whicher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task forceLouis P Garrison, Adrian Towse, Andrew Briggs, et al.
Schizophrenia Research|September 18, 2004
The heterogeneity of schizophrenia in disease statesPenny E Mohr, C Michael Cheng, Karl Claxton, et al.
Contemporary Clinical Trials|July 17, 2012
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United StatesKenneth G Saag, Penny E Mohr, Laura Esmail, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Policy Analysis Brief. W Series|July 9, 2004
The implementation of Medicare's outpatient prospective payment system and specific concerns for rural hospitalsPenny E Mohr, Sreelata Kintala
Journal of Managed Care & Specialty Pharmacy|May 27, 2014
Medical and pharmacy coverage decision making at the population levelPenny E Mohr, Sean R Tunis
Pharmacoeconomics|January 21, 2010
Access with evidence development: the US experiencePenny E Mohr, Sean R Tunis
Arthritis and Rheumatism|May 30, 2009
Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritisJennifer M Polinski, Penny E Mohr, Lorraine Johnson
Schizophrenia Research|September 18, 2004
Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scoresLeslie A Lenert, Ann P Sturley, Mark H Rapaport, et al.
Contemporary Clinical Trials|September 4, 2013
Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payersSeema S Sonnad, C Daniel Mullins, Danielle Whicher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task forceLouis P Garrison, Adrian Towse, Andrew Briggs, et al.
Schizophrenia Research|September 18, 2004
The heterogeneity of schizophrenia in disease statesPenny E Mohr, C Michael Cheng, Karl Claxton, et al.
Contemporary Clinical Trials|July 17, 2012
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United StatesKenneth G Saag, Penny E Mohr, Laura Esmail, et al.
Pageof 1